Prasugrel + Clopidogrel
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Coronary Artery Disease
Conditions
Coronary Artery Disease
Trial Timeline
Feb 1, 2010 → Jun 1, 2010
NCT ID
NCT01014624About Prasugrel + Clopidogrel
Prasugrel + Clopidogrel is a approved stage product being developed by Daiichi Sankyo for Coronary Artery Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01014624. Target conditions include Coronary Artery Disease.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (10)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01327534 | Phase 3 | Completed |
| NCT01260584 | Approved | Completed |
| NCT01107912 | Phase 1 | Completed |
| NCT01107925 | Phase 1 | Completed |
| NCT01014624 | Approved | Completed |
| NCT00910299 | Phase 2 | Terminated |
| NCT00830960 | Phase 3 | Completed |
| NCT00642174 | Phase 2 | Completed |
| NCT00385944 | Phase 2 | Completed |
| NCT00097591 | Phase 3 | Completed |
Competing Products
20 competing products in Coronary Artery Disease